skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature

Review

(2647) Views  (941) Full article downloads

Authors: Alisa Carman Gotte

Published Date May 2009 Volume 2009:1 Pages 37 - 49
DOI: http://dx.doi.org/10.2147/OARRR.S5103

Alisa Carman Gotte

University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, TX, USA

Abstract: Intra-articular corticosteroid injection (IACI) has been used in the treatment of inflammatory arthritis in adults for over fifty years. Over the last two decades, IACI has become an important tool in the management of juvenile idiopathic arthritis (JIA), particularly in the oligoarthritis subset of JIA. Many factors may affect the efficacy of this treatment modality, although the majority of evidence on this topic is anecdotal, nonconvincing, or conflicting. The review examines the rationale, efficacy, safety, and application of the use of IACI in the treatment of JIA, focusing on factors that affect the outcome following IACI.

Keywords: juvenile idiopathic arthritis, juvenile rheumatoid arthritis, glucocorticoids, treatment, children








Readers of this article also read:

Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Pharmacological modulation of brain levels of glutamate and GABA in rats exposed to total sleep deprivation
Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Family caregivers’ assessment of symptoms in persons with dementia using the GBS-scale: differences in rating after psychosocial intervention – an 18-month follow-up study
An update on belimumab for the treatment of lupus
A case of recurrent bloody tears
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
The epidemiology and treatment of gout
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio